Inclusion criteria: (1) Children and adolescents aged 6 months to younger than 18 years; (2) Pediatric patients treated with dupilumab injection (300 mg/2.0 ml/vial or 200 mg/1.14 ml/vial pre-filled ...

Among other topics, Hudson discussed the success of Dupixent (dupilumab), highlighting that it has reached over $13bn in global sales, which affirms its commercial advantage and sets a milestone for ...

EYLEA HD achieved $6 billion in 2024 sales, with FDA decisions on extended dosing and pre-filled syringes due in 2025 ... Dupixent (dupilumab) is now used to treat over a million patients globally.

Dupixent (dupilumab) is a brand-name injection that ... Dupixent is available as a solution inside single-dose prefilled pens and syringes, given as a subcutaneous injection.

Friendly germs armed with their own biological syringes and poisons could hold the key to overcoming the antimicrobial resistance crisis, according to a new study by biologists at the Universities ...

Dupixent ® (dupilumab) is now used to treat over a million patients globally. The recent approval and launch in chronic obstructive pulmonary disease (COPD) has had a successful start ...

Do not use if you are allergic to dupilumab or to any of the ingredients in DUPIXENT®. Before using DUPIXENT, tell your healthcare provider about all your medical conditions, including if you: have ...

Get Instant Summarized Text (Gist) An HIV outbreak in West Virginia, primarily among people who inject drugs, persists despite federal recommendations for syringe service programs. Political ...

Dupixent (dupilumab) is a brand-name injectable drug prescribed for asthma, eczema, and other inflammatory conditions in some adults and children. Dupixent comes in two forms: pens and syringes.